Milan announce Fikayo Tomori has recovered from COVID and will return to group training today.

The former Chelsea defender tested positive for COVID last week, but the Rossoneri didn’t confirm their defender had contracted the virus.

Now, they announce the 24-year-old is COVID free and will return to group training today.

“AC Milan announces that Fikayo Tomori has tested negative for Covid-19. The player has recovered and will return to training with his teammates today,” the club statement read.

Milan currently have two players out of action due to COVID, Ciprian Tatarusanu, Davide Calabria and Alessio Romagnoli, even if the Serie A giants have not confirmed that the Italy defenders had a positive swab test.

Pierre Kalulu and Matteo Gabbia started Milan’s last two games in centre defence, with the Rossoneri collecting victories against Roma and Venezia conceding only once.

The Rossoneri return to the pitch on Thursday in the quarter-finals of the Coppa Italia against Genoa.

Their next Serie A game is on Monday, January 17, against Spezia at San Siro.

2 thought on “Official: Tomori recovers from COVID”
  1. Great news.

    I hope Milan management forget about signing defenders. Kalulu and Gabbia will be enough backup until the end of the season in case of injuries. We’re out of Europe and our starting center-backs have already had Covid, so probably won’t catch it again until the end of the season once Romagnoli recovers, too.

    Also the names circulating in the media are not exciting at all. Sign an attacking midfielder to play in Diaz’s position instead.

  2. Agreed @Milan Fan, good comments.

    A lot will hinge on Romagnoli at the end of the season whether he will still be at Milan. That will determine our CB business in the next transfer window.

    Def good to go till the end of the season with Kalulu & Gabbia, injuries aside, and all things remaining the same.

    Brahim was doing so well until Covid hit…we may need to be patient but cover/depth won’t be bad in that position at all.

Leave a Reply

Your email address will not be published. Required fields are marked *